Skip to main content
. 2019 Feb 4;5(1):e303. doi: 10.1212/NXG.0000000000000303

Figure 5. Evolutionary sequence conservation.

Figure 5

Human ATP1A1, ATP1A2, and ATP1A3 amino acid sequences were aligned with Sus scrofa ATP1A1 (the species used in protein crystal structures 3KDP and 3WGU), and each residue affected by a disease variant was assigned the conservation score calculated for ATP1A1. (A) The individual conservation scores of all aligning amino acids are shown with score on the Y axis and amino acid sequence (1–1,023) on the X axis. As seen in figure e-1 (links.lww.com/NXG/A134), there is no alignment at the N-terminus, so N-terminal residues do not appear. Each blue spot is one amino acid, and the Na,K-ATPase domains are illustrated in the bar at the bottom. Some patterns of conservation can be discerned, highlighted by transparent boxes: two regions with few or no highly conserved amino acids (lavender) and 3 regions of conserved residues (tan) with practically no low conservation residues (off-white). (B) The ATP1A2 variants (green) and the mild ATP1A3 variants (magenta) have similar distributions. There are 14 cases (∼15%) where homology scores were in the less-conserved half. The C-terminal region has many pathogenic variants in both genes despite lacking the highest conservation scores. Residues E174 and R1008 from figure 6 are marked with arrowheads. (C) The severe ATP1A3 variants had a more restricted distribution. It can be seen that many align with the membrane spans. Although their conservation scores varied widely, none were in the less-conserved half. Of the points that do not lie in one of the 3 clusters of high conservation, 8 were shared by mild and severe ATP1A3 phenotypes (visible as 2 colors per symbol at high magnification). This suggests that intermediate phenotypes tend to have less restricted structure distributions than the most severe phenotypes. (D) All the synonymous (brown; n = 281) and missense (coral pink; n = 145) ATP1A3 variants from gnomAD (138,632 sequences) are plotted to compare to the clustering of mutations.